The study found a negative correlation (r = − 0.2394, P = 0.03) between EZH2 expression and bone metastasis, indicating a higher risk of bone metastasis in patients with high EZH2 expression in primary breast cancer [117]. The gene discussed is EZH2; the disease is breast carcinoma.